Humanization of murine neutralizing antibodies against human herpesvirus 6B
Wang et al. (2019). J Virol·Citations: 14Research
Mouse-derived neutralizing antibodies against HHV-6B risked immunogenicity in humans. Chimeric KH-1 and OHV-3 were built by fusing mouse variable to human constant domains. Chimeric KH-1 retained an IC50 of 0.18 ug/mL, close to the original 0.17 ug/mL.
Author abstract
Human herpesvirus 6B (HHV-6B) establishes lifelong latent infection in most individuals after the primary infection. Encephalitis is the most severe complication caused by both the primary infection and the reactivation of HHV-6B and is the cause of considerable mortality in patients, without any established treatments to date. The humanization of the murine neutralizing antibodies described in this research provided a feasible way to reduce the inherent immunogenicity of the antibodies without changing their neutralizing activities. These newly designed chimeric antibodies against HHV-6B have the potential to be candidates for antivirals for future use.
Identifiers & revision
DOI 10.1128/jvi.02270-18OpenAlex W2921489620PubMed 30842329
